Preliminary scientific studies reveal conolidine may well inhibit particular ion channels, lowering neuronal excitability and limiting suffering signals. This system is particularly pertinent in neuropathic discomfort, in which irregular signaling triggers persistent distress. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR)